UNSPSC 51191934: Thiamine chloride hydrochloride

This classification denotes a b vitamin with the molecular formula C12H17N4OS.Cl. ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M572600E5P, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride, but more generally known as thiamine chloride hydrochloride, which bears US NIH Compound Identifier 1130.

European Medicines Agency schedules thiamine chloride hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10969MIG. Most nations, for tariff purposes, schedule thiamine chloride hydrochloride under HS 29362200. SMILES: CC1C(SC[N+]1CC2CNC(NC2N)C)CCO.CL.[CL-].

UNSPSC 51191934 Thiamine chloride hydrochloride is a Commodity code that should describe individual pharmaceutical or nutritional chemical compounds, but the recent state and local opportunities posted under this code do not align with its nominal scope. The three most recent opportunities solicited industrial chemicals and pharmaceutical services — sodium bisulfite for municipal water treatment, parenteral nutrition solutions and intravenous products for a state correctional system, and DeZurik valve parts and repair services for wastewater treatment — none of which fall within thiamine chloride hydrochloride's pharmaceutical profile. State and local governments appear to be using this code as a catch-all for various chemical and medical supply categories rather than as a specific chemical commodity, creating a mismatch between the code's stated product and the actual procurement activity recorded beneath it.

Recent opportunities span Florida, Washington, and Connecticut. Broward County, Florida posted an RFI on September 18, 2026 (due September 29, 2026) seeking alternative suppliers or equivalents for DeZurik/APCO valves and repair services for wastewater treatment facilities currently supplied exclusively by Controls Specialties, Inc., with requirements for SCADA compatibility and preventive maintenance support. The Washington State Department of Corrections issued an RFQ on September 8, 2026 (due October 7, 2026) for parenteral products, services, and equipment — parenteral nutrition, intravenous solutions, and controlled substances — to supply eight correctional facilities across the state, with a pre-bid conference on September 23, 2026 and aspirational small business, minority-owned, women-owned, and veteran-owned business goals of 25%, 10%, 6%, and 5% respectively. The City of Meriden, Connecticut solicited bids for sodium bisulfite chemical supply for its Water Pollution Control Facility under IFB B027-15 (due July 29, 2026). The code shows little topical coherence across recent activity and does not reflect a reliable procurement signal for firms targeting chemical or pharmaceutical supply in state and local markets.